Comparing the effect of omega-3 with Vitamin E on the treatment of primary dysmenorrhea

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201009044686N1

Enrollment

Registered

2011-01-10

Start date

2010-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea. Primary dysmenorrhoea

Interventions

Intervention 1: Vitamin-E, 400 units, every other day for 2 months. Intervention 2: Salmon fish oil, 500 mg (containing 180 mg of EPA and DHA 129 gram), daily for 2 month.

Treatment - Drugs

Vitamin-E, 400 units, every other day for 2 months

Salmon fish oil, 500 mg (containing 180 mg of EPA and DHA 129 gram), daily for 2 month

Eligibility

Sex/Gender

Female

Age

15 Years to 20 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: People who have primary dysmenorrheal and use irregular NSAIDS and OCP. Exclusion criteria: Patients with secondary dysmenorrhea (endometriosis, adenomyosis, leiomyoma, uterine anomaly, Endometrial Polyps, ovarian cyst).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain duration. Timepoint: at first and two months after intervention. Method of measurement: based on hours.;Pain intensity. Timepoint: at first and 2 months after intevention. Method of measurement: Based on the VAS pain intensity.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mehri Jamilian

Arak University Of Medical Sciences

mjamilian@yahoo.com+98 86 1278 0660

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026